| Literature DB >> 31838785 |
Mohamed Al-Khaled1, Samer Awwad1, Toralf Brüning1.
Abstract
BACKGROUND ANDEntities:
Keywords: hemorrhage; nontraumatic spontaneous intracerebral hemorrhage; prognosis
Mesh:
Substances:
Year: 2019 PMID: 31838785 PMCID: PMC6955838 DOI: 10.1002/brb3.1512
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Figure 1Brain CT scan showed a SICH by a 45‐year‐old patient, firstly diagnosed with blood hypertension. The patient was presented with a weakness on the left side and hypertensive crisis
Figure 2Atypically localized sICB with ventricular extension showed by brain CT scan. A 64‐year‐old woman who were presented with a fast‐progredient altered consciousness
Figure 3MRI scan showed cerebral amyloid angiopathy, several microbleeds in the infra‐ as well extratentorial region. A 67 years patients presented with increasing cognitive impairment in the last year
Baseline characteristics and comparison between survival and death
| Baseline Characteristics | All ( | Surviving ( | Died ( |
|
|---|---|---|---|---|
| Age (years), mean ( | 72 (12.7) | 70 (13) | 77 (11.3) | <.001 |
| Female sex | 313 (51.1%) | 221 (47.5) | 91 (62) | .003 |
| NIHSS, median (IQR) | 10 (4–18) | 7 (3–13) | 20 (16–30) | <.001 |
| Medical history | ||||
| Hypertension | 474 (77.3) | 374 (84) | 99 (71.2) | .002 |
| History of diabetes | 114 (18.6) | 86 (19) | 27 (19.7) | .8 |
| Hypercholesterolemia | 103 (16.8) | 86 (19) | 17 (12.4) | .06 |
| Atrial fibrillation | 127 (20.7 | 92 (20.5) | 35 (25.7) | .2 |
| Alcohol use | 43 (7.0) | 37 (8) | 6 (4.2) | .1 |
| History of epilepsy | 29 (4.7) | 22 (4.9) | 7 (5.0) | 1.0 |
| Prior medication | ||||
| ASA | 161 (26.3) | 128 (29) | 32 (30.5) | .7 |
| Clopidogrel | 28 (4.6) | 21 (4.8) | 6 (6.1) | .4 |
| Oral anticoagulants | 86 (14.0) | 60 (13.8) | 26 (25.2) | .004 |
| Statins | 115 (18.8) | 96 (22) | 19 (18.8) | .5 |
| Hospital stay (days), median (IQR) | 11 (6–16) | 12 (10–17) | 3 (1–6) | <.001 |
| Bleeding localization | ||||
| Lobar region | 282 (46.0) | 192 (41) | 86 (58.5) | <.001 |
| Basal ganglia | 193 (31.5) | 159 (34) | 34 (23.1) | |
| Pons | 18 (2.9) | 10 (2) | 8 (5.4) | |
| Thalamus | 53 (8.6) | 48 (10) | 5 (3.4) | |
| Cerebellum | 38 (6.2) | 32 (7) | 6 (4.1) | |
| Multifocal | 18 (2.9) | 12 (3) | 6 (4.1) | |
| Ventricle | 9 (1.5) | 6 (1.3) | 3 (2.0) | |
| Ventricular extension | 197 (32) | 115 (25) | 82 (56) | <.001 |
| Bleeding etiology | ||||
| Uncertain | 110 (18.0) | 69 (15) | 42 (28.6) | <.001 |
| Hypertensive | 288 (47.1) | 237 (51) | 51 (34.7) | |
| Oral anticoagulation | 66 (10.8) | 46 (10) | 20 (13.6) | |
| Amyloid angiopathy | 67 (10.9) | 58 (13) | 9 (6.1) | |
| Other causes | 81 (13.2) | 56 (12) | 25 (17.0) | |
Values are in absolute number and percentage unless other indicated.
Abbreviations: ASA, acetylsalicylic acid; SD, standard deviation.
Change's by Bonferroni‐corrections are significant.
Indicates rare known causes (e.g., small vessel malformation, brain tumors, sinus venous thrombosis etc).
Baseline characteristics, risk factors, bleeding localization, and complications of patients with spontaneous intracerebral hemorrhage
| Baseline characteristics | Functional outcome at discharge ( |
| |
|---|---|---|---|
|
Good outcome; mRS = ≤2 ( |
Poor outcome; mRS = 3–5 ( | ||
| Age (years), mean ( | 68 (12) | 72 (13) | .002 |
| Female gender | 87 (45.3%) | 125 (50) | .3 |
| NIHSS, median (IQR) | 3 (2–6) | 12 (7–16) | <.001 |
| Medical history | |||
| Arterial hypertension | 156 (82) | 213 (85) | .2 |
| Alcohol abuse | 11 (5.7) | 25 (10) | .1 |
| Diabetes mellitus | 35 (18.3) | 51 (20) | .5 |
| Hypercholesterolemia | 47 (24.6) | 39 (15.6) | .019 |
| Atrial fibrillation | 34 (17.7) | 57 (23) | .2 |
| Prior medication | |||
| ASS | 58 (30.5) | 68 (28) | .6 |
| Clopidogrel | 8 (4) | 13 (5) | .5 |
| Anticoagulants | 26 (14) | 34 (14) | .9 |
| Statin | 47 (25) | 49 (20) | .2 |
| Hospitalization length (days), median (IQR) | 11 (8–13) | 15 (11–20) | <.001 |
| Bleeding localization | |||
| Lobar | 91 (47.4) | 93 (37) | .058 |
| Basal ganglia | 56 (29.2) | 94 (37.5) | |
| Pons | 5 (2.6) | 5 (2.6) | |
| Thalamus | 15 (7.8) | 30 (12) | |
| Cerebellum | 15 (7.8) | 16 (6.4) | |
| Multifocal | 2 (1.0) | 10 (4) | |
| Ventricular | 5 (2.6) | 1 (0.4) | |
| Hypophysis | 1 (0.5) | 0 | |
| Intraventricular extension | 31 (16) | 80 (32) | <.001 |
| Bleeding etiology | |||
| Uncertain | 32 (16.7) | 32 (12.7) | .8 |
| Hypertensive | 89 (46.4) | 139 (55) | |
| Oral anticoagulation | 21 (10.9) | 25 (10) | |
| Amyloid angiopathy | 25 (13.0) | 29 (11.6) | |
| Other causes | 25 (13.0) | 23 (9) | |
Values in numbers and percentage unless otherwise indicated.
Abbreviations: ASS, acetylsalicylic acid; IQR, interquartile range; SD, standard deviation.
Indicates that changes in the Bonferroni methods are significant.
Indicates rare known causes (e.g., small vessel malformation, brain tumors, sinus venous thrombosis etc).